Eternygen GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eternygen GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10816
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eternygen GmbH (Eternygen) is a drug discovery company that offers research and development of innovative drugs for dietary-related metabolic diseases. The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transporter NaCT. It also research and develops NaCT a regulator of lipid metabolism involved in the pathogenesis. Eternygen provides drugs for diseases such as diabetes mellitus, fatty liver, and obesity. The company’s proprietary molecules work on glucose metabolism and hepatic lipid oxidation and acts as a therapeutic target by influencing the mammalian energy metabolism. It works in collaboration with other contract research organizations for drug discovery and pre-clinical development in the field of metabolic diseases. Eternygen is headquartered in Berlin City, Germany.

Eternygen GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eternygen GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eternygen GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Eternygen Raises USD8.4 Million in Series A Financing 10
Eternygen Raises Funds Through Seed Financing Round 11
Partnerships 12
Evotec Enters into Co-Development Agreement with Eternygen 12
Eternygen GmbH – Key Competitors 13
Eternygen GmbH – Key Employees 14
Eternygen GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Eternygen GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eternygen GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eternygen GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eternygen Raises USD8.4 Million in Series A Financing 10
Eternygen Raises Funds Through Seed Financing Round 11
Evotec Enters into Co-Development Agreement with Eternygen 12
Eternygen GmbH, Key Competitors 13
Eternygen GmbH, Key Employees 14

List of Figures
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Eternygen GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carrefour SA:戦略・SWOT・企業財務分析
    Carrefour SA - Strategy, SWOT and Corporate Finance Report Summary Carrefour SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Lianhe Chemical Technology Co., Ltd. (002250):企業の財務・戦略的SWOT分析
    Lianhe Chemical Technology Co., Ltd. (002250) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Spectrum Health System:企業の戦略的SWOT分析
    Spectrum Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Moberg Pharma AB (MOB)-医療機器分野:企業M&A・提携分析
    Summary Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB is a pharmaceutical company that offers medical products for the treatment of skin diseases. The company offers products which include Emtrix, Nalox and Naloc, Kerasal nail, Kerasal foot ointment, Domeboro, Blamex and Balmex adult ca …
  • Bankinter, S.A.:企業の戦略・SWOT・財務情報
    Bankinter, S.A. - Strategy, SWOT and Corporate Finance Report Summary Bankinter, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Bush Industries Inc
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Novozymes AS (NZYM B):企業の財務・戦略的SWOT分析
    Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Transportadora De Gas Del Sur S.A.
    Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report Summary Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Rosehill Resources Inc (ROSE):企業の財務・戦略的SWOT分析
    Rosehill Resources Inc (ROSE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Societe Anonyme Belge de Constructions Aeronautiques:企業の戦略・SWOT・財務分析
    Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report Summary Societe Anonyme Belge de Constructions Aeronautiques - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • Massmart Holdings Limited (MSM):企業の財務・戦略的SWOT分析
    Massmart Holdings Limited (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • UEX Corp (UEX):企業の財務・戦略的SWOT分析
    Summary UEX Corp (UEX) is a junior exploration company. The company undertakes the business of acquisition and development of uranium and cobalt deposits in the Athabasca Basin. Its projects portfolio includes Christie Lake project, West Bear project, Horseshoe-Raven project and Shea Creek project. …
  • GfK SE:企業の戦略・SWOT・財務分析
    GfK SE - Strategy, SWOT and Corporate Finance Report Summary GfK SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Bank Hapoalim Private Banking:企業の戦略・SWOT・財務情報
    Bank Hapoalim Private Banking - Strategy, SWOT and Corporate Finance Report Summary Bank Hapoalim Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Public Gas Corporation SA:企業の戦略的SWOT分析
    Public Gas Corporation SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • 8point3 Energy Partners LP (CAFD):電力:M&Aディール及び事業提携情報
    Summary 8point3 Energy Partners LP (8point3 Energy) is a renewable energy company that owns, operates and acquires solar energy generation projects. The company offers operation and maintenance, project development, and technical services. It operates residential, commercial, industrial, and utility …
  • Origin Energy Ltd (ORG):石油・ガス:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • Itamar Medical Ltd (ITMR)-製薬・医療分野:企業M&A・提携分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that offers bio-medical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a …
  • Calpine Corporation:戦略・SWOT・企業財務分析
    Calpine Corporation - Strategy, SWOT and Corporate Finance Report Summary Calpine Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Asahi Kasei Corp (3407):企業の財務・戦略的SWOT分析
    Asahi Kasei Corp (3407) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆